IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Seconda

Padova, Veneto 35128

0 studies enrolling now · 3 studies all time

What they study most

Fallopian Tube Cancer, Gastric Cancer, Non-Squamous Non-Small Cell Lung Cancer, Ovarian Cancer, Peritoneal Neoplasms

Studies at this site

• A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer — Completed
• A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy — Completed